CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q2 2023 Earnings Call Transcript

That was the last question that we received by mail system. So, that concludes our questions from the audience. So, I will now turn it back to Yehiel Tal, CollPlant’s Chief Executive Officer for any closing remarks. Yehiel?

Yehiel Tal: Yes. Thank you, Eran. As I have stated, we at CollPlant aspire to become the leaders in regenerative medicine, helping people live longer and better, and creating improvements in science through our regenerative technologies. Our goal is to create better alternatives and options for the future such as an unlimited supply of spare parts for the human body, including life saving organs, medical treatment tailored to the individual characteristics of each patient, and the drugs are developed without the need for animal testing. Our vision is to enable a world with unlimited organ supply, regenerative tissue products, and novel drugs and diagnostics that do not rely on animals. In closing, I want to reiterate our upcoming goals for the remainder of 2023 and through the first half of 2024.

We plan to continue to advance development of the paradigm shifting regenerative dermal and soft tissue filler program with AbbVie, initiate a study in large animals with commercial size breast implants to generate additional safety and efficacy data in support of commercialization of this program. Announce next steps for the development of the gut-on-the-chip tissue model of drug discovery and personalized treatment of diseases beginning with ulcerative colitis. Continue to expand our commercial portfolio of rhCollagen based BioInks. And finally form new collaborations with industry leaders to co-develop new medical therapies and applications using our regenerative recombinant human collagen technology. Thank you everyone for your time this morning and for joining us today for today’s conference call.

Operator: This concludes today’s conference call. You may disconnect your lines at this time and we thank you for your participation.